Abstract
Protein tyrosine phosphatases (PTPases) are a prominent focus of drug design studies because of their roles in homeostasis and disorders of metabolism. These studies have met with little success because (1) virtually all inhibitors hitherto exhibit only competitive behavior and (2) a consensus sequence H/V-C-X5-R-S/T characterizes the active sites of PTPases, leading to low specificity of active site directed inhibitors. With protein tyrosine phosphatase-1B (PTP1B) identifed as the target enzyme of the vanadyl (VO2+) chelate bis(acetylacetonato)oxidovanadium(IV) [VO(acac)2] in 3T3-L1 adipocytes [Ou et al. J Biol Inorg Chem 10: 874–886, 2005], we compared the inhibition of PTP1B by VO(acac)2 with other VO2+-chelates, namely, bis(2-ethyl-maltolato)oxidovanadium(IV) [VO(Et-malto)2] and bis(3-hydroxy-2-methyl-4(1H)pyridinonato)oxidovanadium(IV) [VO(mpp)2] under steady-state conditions, using the soluble portion of the recombinant human enzyme (residues 1–321). Our results differed from those of previous investigations because we compared inhibition in the presence of the nonspecific substrate p-nitrophenylphosphate and the phosphotyrosine-containing undecapeptide DADEpYLIPQQG mimicking residues 988–998 of the epidermal growth factor receptor, a relevant, natural substrate. While VO(Et-malto)2 acts only as a noncompetitive inhibitor in the presence of either subtrate, VO(acac)2 exhibits classical uncompetitive inhibition in the presence of DADEpYLIPQQG but only apparent competitive inhibition with p-nitrophenylphosphate as substrate. Because uncompetitive inhibitors are more potent pharmacologically than competitive inhibitors, structural characterization of the site of uncompetitive binding of VO(acac)2 may provide a new direction for design of inhibitors for therapeutic purposes. Our results suggest also that the true behavior of other inhibitors may have been masked when assayed with only p-nitrophenylphosphate as substrate.
Similar content being viewed by others
Abbreviations
- Ac:
-
Acetate
- CM:
-
Carboxymethyl
- DMSO:
-
Dimethyl sulfoxide
- EDTA:
-
N,N,N′,N′-ethylene diamine-tetraacetic acid
- EGFR:
-
Epidermal growth factor receptor
- EGFR988−998 :
-
The phosphotyrosine containing undecapeptide DADEpYLIPQQG simulating residues 988–998 of phosphorylated EGFR
- ENDOR:
-
Electron nuclear double resonance
- EPR:
-
Electron paramagnetic resonance
- IPTG:
-
Isopropyl-β-D-1-thiogalactopyranoside
- IR:
-
Insulin receptor
- IRS-1:
-
Insulin receptor substrate-1
- MES:
-
2-(N-morpholino)-ethanesulfonic acid
- pNPP:
-
para-nitrophenylphosphate
- PTPases:
-
Protein tyrosine phosphatases
- PTP1B:
-
Protein tyrosine phosphatase-1B
- pY:
-
Phosphotyrosine
- UV:
-
Ultraviolet
- VO(acac)2 :
-
Bis(acetylacetonato)oxidovanadium(IV)
- VO(Et-malto)2 :
-
Bis(2-ethyl-maltolato)oxidovanadium(IV)
- VO(Me-malto)2 :
-
Bis(2-methyl-maltolato)oxidovanadium(IV)
- VO(mpp)2 :
-
Bis(3-hydroxy-2-methyl-4(1H)pyridinonato)oxidovanadium(IV)
- TCEP:
-
Tris(2-carboxyethyl)phosphine
- Tris:
-
Tris(hydroxymethyl)aminomethane
References
Tonks NK, Diltz CD, Fischer EH (1988) J Biol Chem 263:6731–67372
Tonks NK, Diltz CD, Fischer EH (1988) J Biol Chem 263:6722–6730
Bakke J, Haj FG (2015) Semin Cell Dev Biol 37:58–65
Sarmiento M, Zhao Y, Gordon SJ, Zhang ZY (1998) J Biol Chem 273:26368–26370
Zhang S, Zhang ZY (2007) Drug Discov Today 12:373–381
Zhang ZY (1998) Crit Rev Biochem Mol Biol 33:1–52
Zhang ZY (2002) Annu Rev Pharmacol Toxicol 42:209–234
He R, Yu ZH, Zhang RY, Wu L, Gunawan AM, Lane BS, Shim JS, Zeng LF, He Y, Chen L, Wells CD, Liu JO, Zhang ZY (2015) ACS Med Chem Lett 6:782–786
Wiesmann C, Barr KJ, Kung J, Zhu J, Erlanson DA, Shen W, Fahr BJ, Zhong M, Taylor L, Randal M, McDowell RS, Hansen SK (2004) Nat Struc Mol Biol 11:730–737
Makinen MW, Brady MJ (2002) J Biol Chem 277:12215–12220
Ou HS, Yan LM, Mustafi D, Makinen MW, Brady MJ (2005) J Inorg Biol Chem 10:874–886
Makinen MW, Salehitazangi M (2014) Coord Chem Rev 279:1–22
Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy AL, Normandin D, Cheng A, Himms-Hagen J, Chan CC, Ramachandran C, Gresser MJ, Tremblay ML, Kennedy BP (1999) Science 283:1544–1548
Makinen MW, Rivera SE, Zhou KI, Brady MJ (2007) In: Kustin K, Pessoa JC, Crans DC (eds) Vanadium: the versatile metal, Am Chem Soc, Washington, DC, pp 82–92
Milarsk KL, Zhang ZY, Dixon JE, Saltiel AR (1993) J Biol Chem 268:23634–23639
Cornish-Bowden A (1986) FEBS Lett 203:3–6
Westley AM, Westley J (1996) J Biol Chem 271:5347–5352
Thompson KH, Liboiron BD, Bellman YSKDD, Setyawati IA, Patrick BO, Karunaratne V, Rawji G, Wheeler J, Sutton K, Bhanot S, Cassidy C, McNeill JH, Yuen VG, Orvig C (2003) J Biol Inorg Chem 8:66–74
Rangel M, Tamura A, Fukushima C, Sakura H (2001) J Biol Inorg Chem 6:128–132
Harris R (1976) Aust J Chem 29:1329–1334
Zhang ZY, Thiemesefler AM, Maclean D, McNamara DJ, Dobrusin EM, Sawyer TK, Dixon JE (1993) Substrate-specificity of the protein–tyrosine phosphatases. Proc. Natl. Acad. Sci. (USA) 90:4446–4450
Puius YA, Zhao Y, Sullivan M, Lawrence DS, Almo SC, Zhang ZY (1997) Proc Natl Acad Sci (USA) 94:13420–13425
Xie LP, Zhang YL, Zhang ZY (2002) Biochemistry 41:4032–4039
Wang SS, Tabernero L, Zhang M, Harms E, Van Etten RL, Stauffacher CV (2000) Biochemistry 39:1903–1914
Sarmiento M, Puius YA, Vetter SW, Keng YF, Wu L, Zhao Y, Lawrence DS, Almo SC, Zhang ZY (2000) Biochemistry 39:8171–8179
Zhang ZY, Thiemesefler AM, MacLean D, McNamara DJ, Dobrusin EM, Sawyer TK, Dixon JE (1993) Proc Natl Acad Sci (USA) 90:4446–4450
Dixon M (1953) Biochem J 55:170–171
Cornish-Bowden A (1974) Biochem J 137:143–144
Amin SS, Cryer K, Zhang B, Dutta SK, Eaton SS, Anderson OP, Miller SM, Reul BA, Brichard SM, Crans DC (2009) Inorg Chem 39:406–416
Crans DC (1998) In: Tracey AS, Crans DC (eds) Vanadium compounds: chemistry, biochemistry, and therapeutic applications. Am Chem Soc, Washington, pp 82–103
McLauchlan CC, Peters BJ, Wilsky GR, Crans DC (2015) Coord Chem Rev 301–302:163–199
Chasteen ND, Francavilla J (1976) J Phys Chem 80:867–871
Albanese NF, Chasteen ND (1978) J Phys Chem 82:910–913
Chasteen ND (1981) In: Berliner LJ, Reuben J (eds) Biol Magn Reson, vol 3. Plenum Press, NY, pp 53–119
Makinen MW, Mustafi D (1995) In: Sigel H, Sigel A (eds) Metal ions in biological systems, vol 31. Marcel Dekker, NY, pp 89–127
Mustafi D, Makinen MW (2005) Inorg Chem 44:5580–5590
Grybos R, Samotus A, Popova N, Bogolitsyn K (1997) Trans Metal Chem 22:61–64
Yuen VG, Orvig C, McNeill JH (2003) Can J Physiol Pharmacol 81:1049–1055
Thompson KH, Orvig C (2003) FASEB J 17:A1132
Setyawati IA, Thompson KH, Yuen VG, Sun Y, Battell M, Lyster DM, Vo C, Ruth TJ, Zeisler S, McNeill JH, Orvig C (1998) J Appl Physiol 84:569–575
Mehdi MZ, Srivastava AK (2005) Arch Biochem Biophys 440:158–164
Thompson KH, Barta CA, Orvig C (2006) Chem Soc Rev 35:545–556
Hanson GR, Sun C, Orvig C (1996) Inorg Chem 35:6507–6512
Buglyo P, Kiss E, Fabian I, Kiss T, Sanna D, Garribba E, Micera G (2000) Inorg Chim Acta 306:174–183
Jukic D, Sabo K, Scitovski R (2007) J Comp Appl Math 201:230–246
Romsicki Y, Kennedy BP, Asante-Appiah E (2003) Arch Biochem Biophys 414:40–50
Rice JA (1988) Mathematical statistics and data analysis. Wadsworth Inc, Belmont, p 595
Schwarz G (1978) Ann Stat 6:461–464
Kuzmic P, Cregar L, Millis SZ, Goldman M (2006) FEBS J 273:3054–3062
Peters KG, Davis MG, Howard BW, Pokross M, Rastogi V, Diven C, Greis KD, Eby-Wilkens E, Maier M, Evdokimov A, Soper S, Genbauffe F (2003) J Inorg Biochem 96:321–330
Huyer G, Liu S, Kelly J, Moffat J, Payette P, Kennedy B, Tsaprailis G, Gresser MJ, Ramachandran C (1997) J Biol Chem 272:843–851
Buglyo P, Crans DC, Nagy EM, Lindo RL, Yang LQ, Smee JJ, Jin WZ, Chi LH, Godzala ME, Willsky GR (2005) Inorg Chem 44:5416–5427
Li M, Ding W, Baruah B, Crans DC, Wang R (2008) J Inorg Biochem 102:1846–1853
Mustafi D, Peng B, Foxley S, Makinen MW, Karczmar GS, Zamora M, Ejnik J, Martin H (2009) J Biol Inorg Chem 14:1187–1197
Segal IH (1993) Enzyme kinetics. John Wiley & Sons, Inc., New York, p 957
Dadke S, Chernoff J (2003) Curr Drug Targets Immune Endocr Metabol Disord 3:299–304
Zhang ZY (2005) Biochim Biophys Acta-Proteins Proteom 1754:100–107
Lee S, Wang Q (2007) Med Res Rev 27:553–573
Yip SC, Saha S, Chernoff J (2010) Trends Biochem Sci 35:442–449
Jia ZC, Barford D, Flint AJ, Tonks NK (1995) Science 268:1754–1758
Choy MS, Li Y, Machado LESF, Kunze MBA, Connors CR, Wei XY, Lidorff-Larsen K, Page R, Peti W (2017) Mol Cell 65:644–658
Tiganis T, Bennett AM (2007) Biochem J 402:1–15
Li X, Wilmanns M, Thornton J, Kohn M (2013) Sci Signal 6:rs10
Zhang ZY (1995) J Biol Chem 270:11199–11204
Acknowledgements
We thank Professor Z. Y. Zhang for providing the DNA for overexpression of human PTP1B. IJR was supported by an NIH Roadmap Training Program (T90 DK070076). PBB was supported by a training Grant of the National Institutes of Health at the Interface of Chemistry and Biology (T32GM008720). This research was supported by Grants from the National Institutes of Health (P50 CA125183 and P30 DK020595) and by the Department of Biochemistry and Molecular Biology at The University of Chicago.
Author information
Authors and Affiliations
Contributions
PBB and SQ synthesized VO(mpp)2 and VO(Et-malto)2, respectively; MAC, JHH, MSH, and IJR overexpressed and purified the enzyme and collected and analyzed preliminary steady-state kinetic data; JHH and MWM conducted the final analysis of kinetic data and wrote the manuscript.
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Hon, J., Hwang, M.S., Charnetzki, M.A. et al. Kinetic characterization of the inhibition of protein tyrosine phosphatase-1B by Vanadyl (VO2+) chelates. J Biol Inorg Chem 22, 1267–1279 (2017). https://doi.org/10.1007/s00775-017-1500-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-017-1500-1